A dual P2X3 and P2X2/3 receptor antagonist
Technical Support & Resources

Visit our FAQ

Contact Us

Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888

Request Technical Support

Technical Support Request

To streamline the process attach the appropriate questionnaire to your inquiry.

Download IHC QuestionnaireDownload WB Questionnaire

View Our Privacy Statement for details on how we use and protect your data. In addition, this site is protected by hCaptcha and its Privacy Policy and Terms of Service apply.

RO-3

Item No. 29635

Technical Information
Formal Name
5-[[4,5-dimethoxy-2-(1-methylethyl)phenyl]methyl]-2,4-pyrimidinediamine
CAS Number
1026582-88-6
Molecular Formula
C16H22N4O2
Formula Weight
Purity
≥98%
Formulation
A crystalline solid
DMF: 20 mg/mlDMSO: 12 mg/mlEthanol: 1 mg/mlPBS (pH 7.2): 0.2 mg/ml
SMILES
CC(C)C1=CC(OC)=C(OC)C=C1CC2=CN=C(N)N=C2N
InChi Code
InChI=1S/C16H22N4O2/c1-9(2)12-7-14(22-4)13(21-3)6-10(12)5-11-8-19-16(18)20-15(11)17/h6-9H,5H2,1-4H3,(H4,17,18,19,20)
InChi Key
PYNPWUIBJMVRIG-UHFFFAOYSA-N
Shipping & Storage Information
Storage
-20°C
Shipping
Room temperature in continental US; may vary elsewhere
Recommended Products

Certificates of Analysis & Batch Specific Data

Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

    Add

    Add

    Add

    Add

    Product Description

    RO-3 is a dual antagonist of the purinergic receptor subtypes P2X3 and P2X2/3 (IC50s = 0.1 and 1.26 μM, respectively).1 It is selective for P2X3 and P2X2/3 over P2X1, P2X2, P2X4, P2X5, and P2X7 receptors (IC50s = >10 μM for all) but is an antagonist of ML1-type melatonin receptors (IC50 = 0.398 μM).

    WARNING This product is not for human or veterinary use.

    References & Product Citations
    Product Description References

    1. Ford, A.P.D.W., Gever, J.R., Nunn, P.A., et alPurinoceptors as therapeutic targets for lower urinary tract dysfunction. Br. J. Pharmacol. 147(Suppl. 2), S132-S143 (2006).